Patient #02 had diffuse bone marrow involvement and developed suspected tumor lysis syndrome one week after receiving only 500 MBq of 177Lu-PSMA-TO-1, and 2 weeks after 500 MBq of 177Lu-PSMA-617. The gene discussed is FOLH1; the disease is Tumor Lysis Syndrome.